Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the page; visible study details appear unchanged.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page shows an updated revision to v3.6.3, indicating an update to the page framework.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page header's revision label was updated from v3.6.0 to v3.6.2, indicating an update to the underlying platform. This change does not modify the study details or other user-facing information.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now displays recruitment status as no longer recruiting, and new navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention/Treatment heading was added/renamed and the revision label updated to v3.6.0.SummaryDifference0.3%

- Check63 days agoChange DetectedThe site revision label was updated to v3.5.5, replacing the previous v3.5.4, indicating a deployment update on the page. This update does not modify study information or user-facing content.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's versioning.SummaryDifference0.0%

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.